Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Flowserve
FLS
$10.3B
| $9.01M | 0.01% |
+207,869
| New | +$9.05M |
|
1402
Argan
AGX
$6.46B
| $9M | 0.01% |
209,623
+80,203
| +62% | +$3.38M |
|
1403
First Merchants
FRME
$2.61B
| $8.99M | 0.01% |
215,500
+203,005
| +1,625% | +$8.68M |
|
1404
Crocs
CROX
$5.8B
| $8.95M | 0.01% |
550,704
-1,396,654
| -72% | -$19.4M |
|
1405
Unisys
UIS
$192M
| $8.93M | 0.01% |
830,903
+568,584
| +217% | +$5.72M |
|
|
ACGN
1406
DELISTED
Aceragen Inc
ACGN
| $8.92M | 0.01% |
35,687
+7,318
| +26% | +$2.01M |
|
|
CELG
1407
CALL
DELISTED
Celgene Corp
CELG
| $8.92M | 0.01% |
+100,000
| New | +$9.6M |
|
|
CELG
1408
PUT
DELISTED
Celgene Corp
CELG
| $8.92M | 0.01% |
+100,000
| New | +$9.6M |
|
1409
Benchmark Electronics
BHE
$2.57B
| $8.91M | 0.01% |
298,589
+258,856
| +651% | +$7.77M |
|
|
PDCE
1410
DELISTED
PDC Energy, Inc.
PDCE
| $8.91M | 0.01% |
181,768
+122,300
| +206% | +$6.44M |
|
|
REGI
1411
DELISTED
Renewable Energy Group, Inc.
REGI
| $8.9M | 0.01% |
695,642
+682,058
| +5,021% | +$7.65M |
|
|
DERM
1412
DELISTED
Dermira, Inc.
DERM
| $8.88M | 0.01% |
1,111,031
+209,050
| +23% | +$4.55M |
|
1413
Quad
QUAD
$522M
| $8.86M | 0.01% |
349,338
+175,663
| +101% | +$4.28M |
|
|
MYOK
1414
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $8.85M | 0.01% |
181,325
-309,425
| -63% | -$16.1M |
|
1415
Children's Place
PLCE
$57.4M
| $8.81M | 0.01% |
65,128
+57,400
| +743% | +$8.34M |
|
1416
ASE Group
ASX
$96B
| $8.8M | 0.01% |
1,211,970
+281,781
| +30% | +$1.98M |
|
1417
CALL
Freeport-McMoran
FCX
$112B
| $8.79M | 0.01% |
500,000
-200,000
| -29% | -$3.75M |
|
|
NRE
1418
DELISTED
NorthStar Realty Europe Corp.
NRE
| $8.77M | 0.01% |
673,821
-53,917
| -7% | -$634K |
|
|
HTBK
1419
DELISTED
Heritage Commerce
HTBK
| $8.71M | 0.01% |
528,473
-85,016
| -14% | -$1.38M |
|
1420
PUT
Intercontinental Exchange
ICE
$91B
| $8.7M | 0.01% |
+120,000
| New | +$8.77M |
|
|
LPNT
1421
DELISTED
LifePoint Health, Inc.
LPNT
| $8.69M | 0.01% |
184,967
-762,612
| -80% | -$36.7M |
|
1422
Zimmer Biomet
ZBH
$19B
| $8.65M | 0.01% |
81,750
-390,214
| -83% | -$45.3M |
|
1423
PUT
T. Rowe Price
TROW
$23.8B
| $8.64M | 0.01% |
+80,000
| New | +$8.91M |
|
1424
St. Joe Company
JOE
$3.96B
| $8.63M | 0.01% |
458,029
-674,212
| -60% | -$12.5M |
|
1425
Iovance Biotherapeutics
IOVA
$3.82B
| $8.63M | 0.01% |
510,364
-139,287
| -21% | -$2.11M |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.